We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

JACK:NASDAQJack In The Box Inc. Analysis

Data as of 2026-04-11 - not real-time

$11.45

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: The stock is trading below its 50‑day and 200‑day moving averages while staying just above the 20‑day average, signaling a bearish medium‑term bias. RSI sits in the low‑mid range, indicating no immediate overbought condition, and the MACD histogram is positive despite both lines being in negative territory, hinting at a tentative bullish crossover. Volume is on the rise, but the 30‑day volatility exceeds 60% and beta is above 1.2, underscoring a highly volatile, market‑sensitive profile. Support sits near the low‑52‑week trough and resistance is just above the recent high, framing a narrow trading range.
Fundamental outlook: Revenue has slipped modestly year‑over‑year and the company posted a negative profit margin, yet operating margin remains positive and EBITDA is solid, suggesting core operations retain profitability. The balance sheet is strained with debt far outweighing cash and a negative book value per share, making the current dividend yield of over 15% appear unsustainable. Forward earnings estimates turn positive and analyst price targets imply nearly 100% upside, but the high debt load, negative equity, and recent earnings miss temper optimism. Overall, the stock presents a deep discount to future expectations but carries significant financial and execution risks.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price below 50‑day and 200‑day SMAs
  • High short‑term volatility and beta
  • Increasing volume but bearish trend direction

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Forward EPS turning positive
  • Analyst price targets suggest ~100% upside
  • Undervaluation indicated by low forward P/E

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Heavy debt burden and negative equity
  • Dividend yield likely unsustainable
  • Consumer‑cyclical exposure to discretionary spending

Key Metrics & Analysis

Financial Health

Revenue Growth-5.80%
Profit Margin-8.09%
P/E Ratio3.0
ROA4.58%
P/B Ratio-0.2
Op. Cash Flow$75.3M
Free Cash Flow$-25618750

Technical Analysis

TrendBearish
RSI42.9
Support$8.92
Resistance$13.17
MA 20$11.01
MA 50$15.36
MA 200$18.26
MACDBullish
VolumeIncreasing
Fear & Greed Index87.09

Valuation

Target Price$22.88
Upside/Downside99.85%
GradeUndervalued
TypeBlend
Dividend Yield15.71%

Risk Assessment

Beta1.29
Volatility61.50%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.